+1 347 708 0418
Targeted Drug HER2 Inhibitors for NSCLC market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Targeted Drug HER2 Inhibitors for NSCLC market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Afatinib
Trastuzumab
Other
Segment by Application
Squamous Cell Carcinoma of NSCLC
Adenocarcinoma of NSCLC
Large Cell Carcinoma of NSCLC
By Company
Boehringer-Ingelheim
Roche
Mylan
Biocon
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Afatinib
1.2.3 Trastuzumab
1.2.4 Other
1.3 Market by Application
1.3.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Squamous Cell Carcinoma of NSCLC
1.3.3 Adenocarcinoma of NSCLC
1.3.4 Large Cell Carcinoma of NSCLC
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Perspective (2017-2028)
2.2 Targeted Drug HER2 Inhibitors for NSCLC Growth Trends by Region
2.2.1 Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Targeted Drug HER2 Inhibitors for NSCLC Historic Market Size by Region (2017-2022)
2.2.3 Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Region (2023-2028)
2.3 Targeted Drug HER2 Inhibitors for NSCLC Market Dynamics
2.3.1 Targeted Drug HER2 Inhibitors for NSCLC Industry Trends
2.3.2 Targeted Drug HER2 Inhibitors for NSCLC Market Drivers
2.3.3 Targeted Drug HER2 Inhibitors for NSCLC Market Challenges
2.3.4 Targeted Drug HER2 Inhibitors for NSCLC Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Revenue
3.1.1 Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Revenue (2017-2022)
3.1.2 Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Players (2017-2022)
3.2 Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Targeted Drug HER2 Inhibitors for NSCLC Revenue
3.4 Global Targeted Drug HER2 Inhibitors for NSCLC Market Concentration Ratio
3.4.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Drug HER2 Inhibitors for NSCLC Revenue in 2021
3.5 Targeted Drug HER2 Inhibitors for NSCLC Key Players Head office and Area Served
3.6 Key Players Targeted Drug HER2 Inhibitors for NSCLC Product Solution and Service
3.7 Date of Enter into Targeted Drug HER2 Inhibitors for NSCLC Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Drug HER2 Inhibitors for NSCLC Breakdown Data by Type
4.1 Global Targeted Drug HER2 Inhibitors for NSCLC Historic Market Size by Type (2017-2022)
4.2 Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Type (2023-2028)
5 Targeted Drug HER2 Inhibitors for NSCLC Breakdown Data by Application
5.1 Global Targeted Drug HER2 Inhibitors for NSCLC Historic Market Size by Application (2017-2022)
5.2 Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size (2017-2028)
6.2 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type
6.2.1 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017-2022)
6.2.2 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2023-2028)
6.2.3 North America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2017-2028)
6.3 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application
6.3.1 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017-2022)
6.3.2 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2023-2028)
6.3.3 North America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2017-2028)
6.4 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country
6.4.1 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2017-2022)
6.4.2 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size (2017-2028)
7.2 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type
7.2.1 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017-2022)
7.2.2 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2023-2028)
7.2.3 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2017-2028)
7.3 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application
7.3.1 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017-2022)
7.3.2 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2023-2028)
7.3.3 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2017-2028)
7.4 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country
7.4.1 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2017-2022)
7.4.2 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size (2017-2028)
8.2 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type
8.2.1 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2017-2028)
8.3 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application
8.3.1 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2017-2028)
8.4 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region
8.4.1 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size (2017-2028)
9.2 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type
9.2.1 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017-2022)
9.2.2 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2023-2028)
9.2.3 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2017-2028)
9.3 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application
9.3.1 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017-2022)
9.3.2 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2023-2028)
9.3.3 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2017-2028)
9.4 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country
9.4.1 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2017-2022)
9.4.2 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size (2017-2028)
10.2 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type
10.2.1 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2017-2028)
10.3 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application
10.3.1 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2017-2028)
10.4 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country
10.4.1 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Boehringer-Ingelheim
11.1.1 Boehringer-Ingelheim Company Details
11.1.2 Boehringer-Ingelheim Business Overview
11.1.3 Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Introduction
11.1.4 Boehringer-Ingelheim Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
11.1.5 Boehringer-Ingelheim Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Targeted Drug HER2 Inhibitors for NSCLC Introduction
11.2.4 Roche Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
11.2.5 Roche Recent Developments
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Targeted Drug HER2 Inhibitors for NSCLC Introduction
11.3.4 Mylan Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
11.3.5 Mylan Recent Developments
11.4 Biocon
11.4.1 Biocon Company Details
11.4.2 Biocon Business Overview
11.4.3 Biocon Targeted Drug HER2 Inhibitors for NSCLC Introduction
11.4.4 Biocon Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
11.4.5 Biocon Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Afatinib
Table 3. Key Players of Trastuzumab
Table 4. Key Players of Other
Table 5. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Region (2017-2022)
Table 9. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Region (2023-2028)
Table 11. Targeted Drug HER2 Inhibitors for NSCLC Market Trends
Table 12. Targeted Drug HER2 Inhibitors for NSCLC Market Drivers
Table 13. Targeted Drug HER2 Inhibitors for NSCLC Market Challenges
Table 14. Targeted Drug HER2 Inhibitors for NSCLC Market Restraints
Table 15. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Share by Players (2017-2022)
Table 17. Global Top Targeted Drug HER2 Inhibitors for NSCLC by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug HER2 Inhibitors for NSCLC as of 2021)
Table 18. Ranking of Global Top Targeted Drug HER2 Inhibitors for NSCLC Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Targeted Drug HER2 Inhibitors for NSCLC Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Targeted Drug HER2 Inhibitors for NSCLC Product Solution and Service
Table 22. Date of Enter into Targeted Drug HER2 Inhibitors for NSCLC Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Type (2017-2022)
Table 26. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Type (2023-2028)
Table 28. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Share by Application (2017-2022)
Table 30. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Share by Application (2023-2028)
Table 32. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2023-2028) & (US$ Million)
Table 62. Boehringer-Ingelheim Company Details
Table 63. Boehringer-Ingelheim Business Overview
Table 64. Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Product
Table 65. Boehringer-Ingelheim Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
Table 66. Boehringer-Ingelheim Recent Developments
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Targeted Drug HER2 Inhibitors for NSCLC Product
Table 70. Roche Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
Table 71. Roche Recent Developments
Table 72. Mylan Company Details
Table 73. Mylan Business Overview
Table 74. Mylan Targeted Drug HER2 Inhibitors for NSCLC Product
Table 75. Mylan Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
Table 76. Mylan Recent Developments
Table 77. Biocon Company Details
Table 78. Biocon Business Overview
Table 79. Biocon Targeted Drug HER2 Inhibitors for NSCLC Product
Table 80. Biocon Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
Table 81. Biocon Recent Developments
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type: 2021 VS 2028
Figure 2. Afatinib Features
Figure 3. Trastuzumab Features
Figure 4. Other Features
Figure 5. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application: 2021 VS 2028
Figure 6. Squamous Cell Carcinoma of NSCLC Case Studies
Figure 7. Adenocarcinoma of NSCLC Case Studies
Figure 8. Large Cell Carcinoma of NSCLC Case Studies
Figure 9. Targeted Drug HER2 Inhibitors for NSCLC Report Years Considered
Figure 10. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Region: 2021 VS 2028
Figure 13. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Players in 2021
Figure 14. Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug HER2 Inhibitors for NSCLC as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Targeted Drug HER2 Inhibitors for NSCLC Revenue in 2021
Figure 16. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size Market Share by Type (2017-2028)
Figure 18. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size Market Share by Application (2017-2028)
Figure 19. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size Share by Country (2017-2028)
Figure 20. United States Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size Market Share by Type (2017-2028)
Figure 24. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size Market Share by Application (2017-2028)
Figure 25. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size Share by Country (2017-2028)
Figure 26. Germany Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size Share by Region (2017-2028)
Figure 36. China Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size Share by Country (2017-2028)
Figure 46. Mexico Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size Share by Country (2017-2028)
Figure 52. Turkey Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Boehringer-Ingelheim Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
Figure 56. Roche Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
Figure 57. Mylan Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
Figure 58. Biocon Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Buy
